New Spray For Severe Allergic Reactions
This summer, the FDA granted fast-track approval to neffy, the first nasal epinephrine spray, offering a promising alternative to injectable epinephrine for treating anaphylaxis. According to the FDA, patients often delay or avoid treatment due to fear of injections. Neffy provides an easier, needle-free option, achieving similar serum epinephrine levels,